Abstract: A technique is provided to limit the number of vehicles required during a well project involving a plurality of well construction related procedures. The technique utilizes a modular unit, e.g. a vehicle, and a plurality of modules that may be interchanged on the modular unit according to the scheduled well procedure. A separate crane unit can be used to move the modules to and from the vehicle as required for specific phases of well construction.

Abstract: A technique is provided to limit the number of vehicles required during a well project involving a plurality of well construction related procedures. The technique utilizes a modular unit, e.g. a vehicle, and a plurality of modules that may be interchanged on the modular unit according to the scheduled well procedure. A separate crane unit can be used to move the modules to and from the vehicle as required for specific phases of well construction.

Abstract: A technique is provided to limit the number of vehicles required during a well project involving a plurality of well construction related procedures. The technique utilizes a modular unit, e.g. a vehicle, and a plurality of modules that may be interchanged on the modular unit according to the scheduled well procedure. A separate crane unit can be used to move the modules to and from the vehicle as required for specific phases of well construction.

Abstract: Packaging systems for medical devices, such as surgical instruments, implants, and prostheses, are provided herein. In one embodiment, the packaging system comprises a blister tray that is at least semi-transparent and has at least one cavity capable of containing a medical device or portion thereof. The system additionally comprises a card having at least one window, wherein the at least one cavity in the blister tray protrudes through the at least one window in the card. The packaging systems provide a convenient, informative, and preferably sterile means of distributing medical devices.

Abstract: A technique is provided to limit the number of vehicles required during a well project involving a plurality of well construction related procedures. The technique utilizes a transport vehicle able to receive a plurality of equipment modules that may be used for specific well related procedures. The modules may be interchanged with other vehicles for performance of specific procedures corresponding to specific modules.

Abstract: The present invention relates to a method of treating patients with solid tumors, leukemias, and other malignancies using a combination of zosuquidar, daunorubicin, and cytarabine. The invention is also directed to pharmaceutical formulations comprising zosuquidar, daunorubicin, and cytarabine. The formulations are particularly effective in treating relapsed Acute Myelogenous Leukemia (AML).

Abstract: The present invention relates to a method of determining P-glycoprotein expression and/or function for a patient with solid tumors, leukemias, and other malignancies. The invention also relates to using a P-glycoprotein expression and/or function diagnostic in conjunction with methods for treating solid tumors, leukemias, and other malignancies with a chemotherapeutic agent in combination with zosuquidar. The methods are particularly effective in treating acute myelogenous leukemia, metastatic breast cancer, and other cancers expressing P-glycoprotein, wherein the P-glycoprotein expression and/or function is used to select a treatment option for the patient.

Abstract: The present invention relates to a method of treating patients with leukemias, solid tumors, and other malignancies using chemotherapeutic agents in combination with zosuquidar that has been solubilized by a modified cyclodextrin, such as sulfobutylcyclodextrin or hydroxypropyl cyclodextrin. The invention is also directed to pharmaceutical formulations comprising zosuquidar in combination with a modified cyclodextrin.

Abstract: The present invention relates to a method of treating patients with solid tumors, leukemias, and other malignancies using a combination of zosuquidar and a calicheamicin-antibody conjugate, such as Mylotarg. The invention is also directed to pharmaceutical formulations comprising zosuquidar and calicheamicin-antibody conjugates. The formulations are particularly effective in treating relapsed Acute Myelogenous Leukemia (AML) and metastatic breast cancer.

Abstract: The present invention relates to a method of treating patients with solid tumors, leukemias, and other malignancies using a combination of zosuquidar, daunorubicin, and cytarabine. The invention is also directed to pharmaceutical formulations comprising zosuquidar, daunorubicin, and cytarabine. The formulations are particularly effective in treating relapsed Acute Myelogenous Leukemia (AML).

Abstract: The present invention relates to a method of determining P-glycoprotein expression and/or function for a patient with solid tumors, leukemias, and other malignancies. The invention also relates to using a P-glycoprotein expression and/or function diagnostic in conjunction with methods for treating solid tumors, leukemias, and other malignancies with a chemotherapeutic agent in combination with zosuquidar. The methods are particularly effective in treating acute myelogenous leukemia, metastatic breast cancer, and other cancers expressing P-glycoprotein, wherein the P-glycoprotein expression and/or function is used to select a treatment option for the patient.

Abstract: The present invention relates to a method of treating patients with solid tumors, leukemias, and other malignancies using a combination of zosuquidar, daunorubicin, and cytarabine. The invention is also directed to pharmaceutical formulations comprising zosuquidar, daunorubicin, and cytarabine. The formulations are particularly effective in treating relapsed Acute Myelogenous Leukemia (AML).

Abstract: The present invention relates to a method of treating patients with leukemias, solid tumors, and other malignancies using chemotherapeutic agents in combination with zosuquidar that has been solubilized by a modified cyclodextrin, such as sulfobutylcyclodextrin or hydroxypropyl cyclodextrin. The invention is also directed to pharmaceutical formulations comprising zosuquidar in combination with a modified cyclodextrin.

Abstract: The present invention relates to a method of treating patients with solid tumors, leukemias, and other malignancies using a combination of zosuquidar and a calicheamicin-antibody conjugate, such as Mylotarg. The invention is also directed to pharmaceutical formulations comprising zosuquidar and calicheamicin-antibody conjugates. The formulations are particularly effective in treating relapsed Acute Myelogenous Leukemia (AML) and metastatic breast cancer.

Abstract: The present invention relates to a method of treating patients with leukemias, solid tumors, and other malignancies using chemotherapeutic agents in combination with zosuquidar that has been solubilized by a modified cyclodextrin, such as sulfobutylcyclodextrin or hydroxypropyl cyclodextrin. The invention is also directed to pharmaceutical formulations comprising zosuquidar in combination with a modified cyclodextrin.

Abstract: A technique is provided to limit the number of vehicles required during a well project involving a plurality of well construction related procedures. The technique utilizes a modular unit, e.g. a vehicle, and a plurality of modules that may be interchanged on the modular unit according to the scheduled well procedure. A separate crane unit can be used to move the modules to and from the vehicle as required for specific phases of well construction.